|
|
|
|
Perspective
|
|
A Wound Healer, Ampucare can Inhibits Bacterial Growth
|
|
Idress Hamad Attitalla
|
|
|
ABSTRACT
|
|
|
|
|
|
|
|
Bacteria are small living prokaryotes and important part of biological environment
due to their various beneficial and health threatening activities. Their infection
can cause severe illness in humans e.g. lyme borreliosis, relapsing fever and
tularaemia (Brouqui et al., 2004). In human bodies
bacteria form different communities in mouth, gut, skin etc.; highly complex
bacterial communities are found on skin (Costello et
al., 2009). The inhabitants of these communities vary from individual
to individual and can determine the severity of a disease in its particular
habitat. Nowadays several antibacterial drugs are available in market among
which cephalosporins, macrolides, fluoroquinolones and penicillins are the leading
drug groups, responsible for 80% sales of total drugs (Kresse
et al., 2007). These antibacterial drugs are highly popular among
peoples of weak immune system. But many bacteria e.g., Escherichia coli,
Staphylococcus aureus, Pseudomonas spp. etc. have gain resistance against
these drugs and now only few drugs are found effective against resistant bacterial
strains (Bhowmick and Rashid, 2004). Thus there is a
need of developing new competent antibiotic, which might be achieved through
exploring medicinal plants. These plants are used as food additives and act
as a source of natural antibacterial compounds e.g. phenols (Dorman
and Deans, 2000). There antibacterial agents are always used in modified
form i.e., extracting essential oils etc. Other types of decoctions (crude extracts)
can also be used for this purpose; these extracts are obtained from roots, leaf,
fruits, pod, stem, flower, seeds, bark and whole plant (Kumar
et al., 2006). A combination of different plants can also be employed
as an antibiotic. As a topical polyherbal anti-acne gel derived from Garcinia
mangostana and Aloe vera has inhibitory property against Propionibacterium
acne and Staphylococcus epidermidis (Bhaskar
et al., 2009). Moreover its bacterial inhibitory activity was better
than a market gel, clindamycin phosphate. Other than bactericidal activity the
use of these plants can also provide protection from several diseases e.g. inflammation,
cancer, wounds, diabetes etc. (Hamman, 2008; Karim
et al., 2011; Sohail et al., 2011).
So, antibacterial activity is characteristic of many plants used in daily routine
and their use can provide protection from non-bacterial diseases.
Ampucare is a polyherb formulation with neem (Azadirachta indica) and
turmeric (Curcuma longa) as its main ingredients. It is extensively used
in wound healing and has antioxidant activities, its topical treatment in rats
fasten the process of muscles healing (Dwivedi et al.,
2008). For which, it lowers the malondialdehyde (an oxidation product) levels
and increase the proteins, hydroxyproline and antioxidant enzymes levels. According
to Shrivastava et al. (2009) Ampucare could be
used as antibacterial agent, it inhibited the growth of E. coli, Staphylococcus
aureus, Klebsiella pneumoniae and Proteus vulgaris. They conducted
in vitro time based studies to evaluate the effects of Ampucare stored
in different conditions on bacterial strains. In these experiments Ampucare
showed significant inhibition of all bacterial strains and its bactericidal
activity increased with time. As E. coli colony counts was 6.16 within
first hour of Ampucare application which decreased up to 2.30 log10
cfu (colony-forming unit) mL-1 after 6 h. In addition the storage
conditions (Ampucare-A: room temperature, B: 0°C for 5 h and C: centrifuged
for 1 h) did not cause any effect on its inhibitory activity. Since within 0-6
h of killing, Ampucare-A E. coli colony counts were 6.16 to 2.30, Ampucare-B;
6.22 to 2.30 and for Ampucare-C 6.50 to 2.30 log10 cfu mL-1.
Thus there was not any significant difference in Ampucare A, B, and C antibacterial
activity against E. coli, although at some times minute differences were
found. Thus against a specific bacterial strain no difference was found in Ampucare-A,
B and C activity. Similar results were obtained for other bacterial strains
but Ampucare (A, B and C) was differentially active against these bacterial
strains. As Ampucare-A 0-6 h inhibition logarithmic value for P. vulgaris,
K. pneumoniae, S. aureus and E. coli was 6.36-2.70, 6.41-2.30, 6.16-2.30
and 6.16 to 2.30 log10 cfu mL-1, respectively. Hence there
was only minimal difference in Ampucare activity against different bacterial
strains, while large similarity in its activity was found against S. aureus
and E. coli strains. Thus Ampucare showed an excellent in vitro
antibacterial activity within 6 h of its application against several bacterial
strains. So it could be appreciated as bactericidal as well as wound healer
agent and more research on its antibacterial mode of action would favor its
use.
Bacteria live in mouth, gut and skin of humans and can cause serious diseases.
Their growth can be inhibited through the application of various commercial
antibiotics, only if bacterium has not developed resistant against them. The
antibiotic resistance has increased the demands of new bactericidal products
with reliable results, which directed the founders towards plants antibacterial
sources. Plant derived products have multipurpose effects and are used to treat
number of human ailments. Shrivastava et al. (2009)
found that Ampucare, a polyherbal wound healer formulation can significantly
stop the growth of various bacterial strains within 6 h of its application.
Moreover the storage conditions did not affect its bactericidal activity, hence
could be considered as potent antibacterial agent. It is previously used to
treat wounds; therefore its topical application for antibacterial purposes can
be trusted.
|
REFERENCES |
1: Brouqui, P., F. Bacellar, G. Baranton, R.J. Birtles and A. Bjoersdorff et al., 2004. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin. Microbiol. Infect., 10: 1108-1132. PubMed |
2: Costello, E.K., C.L. Lauber, M. Hamady, N. Fierer, J.I. Gordon and R. Knight, 2009. Bacterial community variation in human body habitats across space and time. Science, 326: 1694-1697. CrossRef | Direct Link |
3: Kresse, H., M.J. Belsey and H. Rovini, 2007. The antibacterial drugs market. Nature Rev. Drug Discovery, 6: 19-20. CrossRef | Direct Link |
4: Bhowmick, B.K. and H. Rashid, 2004. Prevalence and antibiotic susceptibility of E. coli isolated from Urinary Tract Infection (UTI) in Bangladesh. Pak. J. Biol. Sci., 7: 717-720. CrossRef | Direct Link |
5: Dorman, H.J.D. and S.G. Deans, 2000. Antimicrobial agents from plants: Antibacterial activity of plant volatile oils. J. Applied Microbiol., 88: 308-316. CrossRef | Direct Link |
6: Kumar, V.P., N.S. Chauhan, H. Padh and M. Rajani, 2006. Search for antibacterial and antifungal agents from selected Indian medicinal plants. J. Ethnopharmacol., 107: 182-188. CrossRef | PubMed | Direct Link |
7: Bhaskar, G., S. Arshia and S.R.B. Priyadarshini, 2009. Formulation and evaluation of topical polyherbal antiacne gels containing Garcinia mangostana and Aloe vera. Phcog. Mag., 5: 93-99. Direct Link |
8: Hamman, J.H., 2008. Composition and Applications of Aloe vera leaf gel. Molecules, 13: 1599-1616. CrossRef | PubMed |
9: Dwivedi, V.K., M. Chaudhary, A. Soni, V. Niathani and S.M. Shrivastava, 2008. Therapeutic role of ampucare in alteration of antioxidant activities and wound healing effect in Mus musculus mice. J. Ecophysiol. Occup. Health, 8: 167-176.
10: Shrivastava, S.M., S. Kumar and M. Chaudhary, 2009. Time-kill curve studies of ampucare against Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae and Proteus vulgaris. Res. J. Med. Plant, 3: 116-122. CrossRef | Direct Link |
11: Karim, A., M.N. Sohail, S. Munir and S. Sattar, 2011. Pharmacology and phytochemistry of Pakistani herbs and herbal drugs used for treatment of diabetes. Int. J. Pharmacol., 7: 419-439. CrossRef |
12: Sohail, M.N., F. Rasul, A. Karim, U. Kanwal and I.H. Attitalla, 2011. Plant as a source of natural antiviral agents. Asian J. Anim. Vet. Adv., 6: 1125-1152. CrossRef |
|
|
|
 |